Baker Heart and Diabetes Institute

The work at Baker Heart and Diabetes Institute extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.

Et nærbilde av en klokke — Copyright (c) Steve Buissinne / Pixabay

The Clinical Research Domain concentrates on human or clinical research. It has a particular focus on using imaging and other diagnostic tools to better inform the understanding of disease development and treatment, clinical trials to evaluate new treatments and health services research to inform how health care can be best delivered. Many of our researchers are also clinicians who work in a clinic or hospital setting. They are predominantly heart and diabetes specialists whose research is informed by the needs of their patients.

The Institute has had a strong focus on Aboriginal health for more than 10 years, with a dedicated research facility opening in Alice Springs adjacent to the Alice Springs Hospital in 2007. A growing team of researchers in Central Australia and across the country have forged important partnerships and collaborations to help address the profound disadvantage experienced by Aboriginal people through scientific research that is rigorous, culturally appropriate and ethically sound.

The research undertaken is based on community needs, with a strong focus on working with local providers to build knowledge and provide practical contributions to Aboriginal and Torres Strait Islander people’s health.

Our Mission

To reduce death and disability from cardiovascular disease, diabetes and other related health disorders

The Baker Heart and Diabetes Institute measures its performance, and seeks to be judged by its stakeholders and peers, on the contribution it is able to make in three areas:

Scholarly achievement measured by publication number and impact, citation rates, and contribution to academic discourse which effect paradigm shifts in the discipline.
Translation of research output in clinical, commercial and policy environments where new knowledge generated through the Institute's research activity have an impact on the lives of people with, or at risk, of cardiovascular disease and diabetes.
Contributions to clinical service delivery and preventive health initiatives, through the successful operation of its clinics and clinical service partnerships, and the development and management of preventive health programs which contribute to the public understanding of how to prevent and manage disease.